MAPT and Alzheimer disease: Evaluation of Aβ pathology in AD transgenic mice and human brains; automated quantification of Aβ plaques with ClearMAP (Liebmann et al., 2016). Imaging of temporal/spatial progression of tau neuropathology in EC-tau mice (Fu et al., 2016).